AstraZeneca CEO Soriot defends COVID-19 vaccine, blasts 'armchair generals' for unhelpful criticism: FT How Piedmont Healthcare turned to a mobile app to streamline COVID-19 vaccine distribution Moderna taps Samsung for fill-finish duties on 'hundreds of millions' of COVID-19 vaccine doses Breathonix's 60-second COVID-19 breathalyzer test receives provisional green light in Singapore OptumRx analysts see more pharmacy fraud activity amid COVID-19 Looking for an edge over Merck, Pfizer begins testing its COVID-19 vaccine and next-gen pneumococcal shot together COVID-19 tracker: Pfizer kicks off co-administration study Mayo Clinic reports $243M operating income, $3.7B total revenue to kick off 2021 The top 15 highest-paid biopharma CEOs of 2020 Featured Story | By Angus Liu AstraZeneca CEO Pascal Soriot has had enough of vacuous criticism toward its University of Oxford-partnered COVID-19 vaccine. He described the attacks at the vaccine as “traumatic” and defended the company's work against “armchair generals.” read more |
| |
|---|
|
Top Stories By Brian T. Horowitz During the COVID-19 pandemic, Piedmont Healthcare, an 11-hospital health system in Georgia, pivoted to use its Piedmont Now app to coordinate vaccine distribution. The health system is now looking at how to integrate more virtual care options into the mobile app. read more By Fraiser Kansteiner As Moderna continues to beef up its COVID-19 vaccine production work, it's drawing on some serious muscle from South Korea. The biotech has unveiled a pact with Samsung Biologics that will see the CDMO crank out "hundreds of millions" of doses from its facilities in Incheon. read more By Andrea Park Singapore’s Ministry of Health will use the BreFence Go system to test incoming travelers at the Tuas Checkpoint between Singapore and Malaysia, where a negative test is required to enter the city-state. read more By Paige Minemyer There was a significant increase in pharmacy fraud and abuse under the pandemic, analysts at OptumRx say. read more By Kevin Dunleavy In its battle with Merck for next-gen pneumococcal vaccine supremacy, Pfizer is attempting to gain an advantage as it kicks off a test of co-administered Prevnar 20 and COVID-19 booster shots in adults age 65 and older. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner Pfizer has started a co-administration study of its next-gen pneumococcal candidate with a COVID-19 booster shot. Plus, AstraZeneca's CEO again defended his company's pandemic response. read more By Dave Muoio The nonprofit maintained its strong momentum from late last year, posting another quarter of gains in spite of mixed volumes and mounting costs. read more By Fraiser Kansteiner As COVID-19 vaccines and therapeutics reach the public, the companies involved in the pandemic fight have laid out some eye-popping pay packages for their chief executives. One in particular, coming in at more than $135 million, will likely set a benchmark for years to come. Meanwhile, pandemic players weren't the only ones to reward their helmsmen handsomely in 2020. read more |
